Menai Science Park, Anglesey (A wholly owned subsidiary of Bangor University) are currently recruiting a Managing Director for MSparc.
The government’s Industrial Strategy White Paper, published at the end of November 2017, set out a vision to build a Britain fit for the future, with the life sciences sector seen as essential to powering the economy in the post Brexit world.
Vanguard House, part of Sci-Tech Daresbury, has secured a series of new lettings which has taken the building in the Enterprise Zone to 100 per cent let.
Built in 2011, Vanguard House offers 36,000 sq ft of office and laboratory space providing high-quality accommodation for maturing businesses from both within the campus and through external lettings.
The new companies taking space in the building come from a range of sectors. They are:
• Avenista, Table Reservation & Table Management software solutions
A joint venture has been agreed between Cambridge Science Park (UK) and TusPark (China).
The agreement includes jointly building a state of the art Biohub facility at Cambridge Science Park which will provide labs and offices for early stage biotech and medtech companies as well as grow-on space for more established businesses.
Midlands Innovation, a group of eight universities and one of the UK’s most influential academic collaborations, has launched its plan for collaboration in technology transfer. The announcement was made at an event held at The Shard, London.
World-leading provider of system-level audio solutions, SoundChip, has officially opened its new office space at Sci-Tech Daresbury as it continues to see strong appetite for its innovative wearable sound technology.
UK Government Minister Lord Bourne visits Glyndŵr University’s world-leading science and innovation centre
Lord Bourne: “Glyndŵr’s OpTIC Centre is leading the way in sustainable business and job creation, taking North Wales’ cutting-edge technology to the world.”
Immunocore Limited, the world’s leading TCR company focused on delivering first-in-class biological therapies that transform lives, has taken laboratory and office space at The Oxford Science Park. In its new premises on the Park, Immunocore will be focused on the development of immunotherapies for infectious diseases, complementing its cancer research at Milton Park in Oxford. The office and laboratory facilities (10,625 sq ft in total) are expected to be operational by the end of the year.